Company intelligence / Profile preview
Innogene Kalbiotech
Singapore, Singaporeinnogene-kalbiotech.com ↗
- Ownership
- Private
- Employees
- ~49
- Development stage
- Commercial
01
Overview
Innogene Kalbiotech has successfully commercialized biosimilars and novel diagnostics—most notably the Mammaprint breast cancer recurrence assay—and continues to run clinical trials for additional biopharmaceuticals. The company has a proven track record of bringing products from development through regulatory approval to market across Asia.
- Therapeutic areas
- OtherOncology
- Modalities
- Novel biologics (including monoclonal antibodies)BiosimilarsDiagnostics (notably precision oncology tests)Vaccines (therapeutic and preventive)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborates with companies for clinical development and distribution; part of the broader Kalbe Group network which includes PT Kalbe Genexine BiologicsAlso works with diagnostic partners such as those involved in Mammaprint
Beyond the preview
Go deeper on Innogene Kalbiotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Innogene Kalbiotech.